Quetiapine attenuates the depressive and anxiolytic-like behavioural changes induced by global cerebral ischemia in mice

Behavioural Brain Research

Volumn 182, Issue 1, 2007, Pages 36-41

  Yan, Bin ^a   He, Jue ^a   Xu, Haiyun ^b   Zhang, Yanbo ^a   Bi, Xiaoying ^a   Thakur, Sonia ^a   Gendron, Alain ^c   Kong, Jiming ^d   Li, Xin Min ^a,e  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ASTRAZENECA   (United Kingdom)

^d UNIVERSITY OF MANITOBA   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Anxiety; Depression; Global cerebral ischemia (GCI); Quetiapine

Indexed keywords

QUETIAPINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DRUG EFFECT; EXPERIMENTAL TEST; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TRANQUILIZING ACTIVITY; TREATMENT DURATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; DEPRESSION; DIBENZOTHIAZEPINES; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; HINDLIMB SUSPENSION; MALE; MICE; PUTAMEN; TYROSINE 3-MONOOXYGENASE;

EID: 34447293701     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.05.002     Document Type: Article

References (43)

1. Bannerman D.M., Grubb M., Deacon R.M., Yee B.K., Feldon J., and Rawlins J.N. Ventral hippocampal lesions affect anxiety but not spatial learning. Behav Brain Res 139 (2003) 197-213
2. Bantsiele G.B., Bentue-Ferrer D., Amiot N., Allain H., Bourin M., and Reymann J.M. Does rat global transient cerebral ischemia serve as an appropriate model to study emotional disturbances?. Fundam Clin Pharmacol 18 (2004) 685-692
3. Blaschko H. Catecholamine synthesis. Br Med Bull 29 (1973) 105-110
4. Bokura H., and Robinson R.G. Long-term cognitive impairment associated with caudate stroke. Stroke 28 (1997) 970-975
5. Bradvik B., Sonesson B., and Holtas S. Spatial impairment following right hemisphere transient ischaemic attacks in patients without carotid artery stenosis. Acta Neurol Scand 80 (1989) 411-418
6. Bryer J.B., Starkstein S.E., Votypka V., Parikh R.M., Price T.R., and Robinson R.G. Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report. J Neuropsychiatry Clin Neurosci 4 (1992) 440-442
7. Chae B.J., and Kang B.J. Quetiapine for hypersexuality and delusional jealousy after stroke. J Clin Psychopharmacol 26 (2006) 331-332
8. Champoux N., Monette J., Monette M., Galbaud du Fort G., Wolfson C., and Le Cruguel J.P. Use of neuroleptics: study of institutionalized elderly people in Montreal, Que. Can Fam Physician 51 (2005) 696-697
9. Chemerinski E., and Levine S.R. Neuropsychiatric disorders following vascular brain injury. Mt Sinai J Med 73 (2006) 1006-1014
10. Costall B., Jones B.J., Kelly M.E., Naylor R.J., and Tomkins D.M. Exploration of mice in a black and white box, validation as a model of anxiety. Pharmacol Biochem Behav 32 (1989) 777-785
11. Decombe R., Bentue-Ferrer D., Allain H., and Van den Driessche J. Alteration of aminergic neurotransmitter release after two consecutive transient global ischaemias: an in vivo microdialysis study in rat. Neurol Res 15 (1993) 192-197
12. Desmond D.W., Moroney J.T., Sano M., and Stern Y. Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 33 (2002) 2254-2260
13. Desmond D.W., Moroney J.T., Sano M., and Stern Y. Mortality in patients with dementia after ischemic stroke. Neurology 59 (2002) 537-543
14. Dhooper A., Young C., and Reid K.H. Ischemia-induced anxiety following cardiac arrest in the rat. Behav Brain Res 84 (1997) 57-62
15. Eisch A.J., and Marshall J.F. Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury. Synapse 30 (1998) 433-445
16. He J., Xu H., Yang Y., Zhang X., and Li X.M. Chronic administration of quetiapine alleviates the anxiety-like behavioural changes induced by a neurotoxic regimen of d, l-amphetamine in rats. Behav Brain Res 160 (2005) 178-187
17. Hodges H., Nelson A., Virley D., Kershaw T.R., and Sinden J.D. Cognitive deficits induced by global cerebral ischaemia: prospects for transplant therapy. Pharmacol Biochem Behav 56 (1997) 763-780
18. Kelly S., McCulloch J., and Horsburgh K. Minimal ischaemic neuronal damage and HSP70 expression in MF1 strain mice following bilateral common carotid artery occlusion. Brain Res 28 914 (2001) 185-195
19. Lasser R.A., and Sunderland T. Newer psychotropic medication use in nursing home residents. J Am Geriatr Soc 46 (1998) 202-207
20. Li X.M., Chlan-Fourney J., Juorio A.V., Bennett V.L., Shrikhande S., Keegan D.L., et al. Differential effects of olanzapine on the gene expression of superoxide dismutase and low affinity nerve growth factor receptor. J Neurosci Res 56 (1999) 72-75
21. Mayberg H.S., Parikh R.M., Morris P.L., and Robinson R.G. Spontaneous remission of post-stroke depression and temporal changes in cortical S2-serotonin receptors. J Neuropsychiatry Clin Neurosci 3 (1991) 80-83
22. Miyamoto S., Duncan G.E., Marx C.E., and Lieberman J.A. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10 (2005) 79-104
23. Muller T., and Reimer J. Quetiapine improves involuntary movements after cerebellar stroke. J Neurol 249 (2002) 1320-1321
24. Nakashima M.N., Ajiki K., Nakashima K., and Takahashi M. Possible role of nitric oxide in anxiety following transient cerebral ischemia in mice. J Pharmacol Sci 91 (2003) 47-52
25. Naritomi H. Experimental basis of multi-infarct dementia: memory impairments in rodent models of ischemia. Alzheimer Dis Assoc Disord 5 (1991) 103-111
26. Nemeth G., Cintra A., Herb J.M., Ding A., Goldstein M., Agnati L.F., et al. Changes in striatal dopamine neurohistochemistry and biochemistry after incomplete transient cerebral ischemia in the rat. Exp Brain Res 86 (1991) 545-554
27. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, London, UK
28. Plamondon H., and Khan S. Characterization of anxiety and habituation profile following global ischemia in rats. Physiol Behav 84 (2005) 543-552
29. Qing H., Xu H., Wei Z., Gibson K., and Li X.M. The ability of atypical antipsychotic drugs versus haloperidol to protect PC12 cells against MPP+-induced apoptosis. Eur J Neurosci 17 (2003) 1563-1570
30. Richards D.A., Obrenovitch T.P., Johonson-Mora A., Islekel S., Symon L., and Curzon G. Effect of global ischaemia, under simulated penumbral conditions, on brain monoamine neurochemistry and subsequent neurological and histological deficits. J Neurochem 61 (1993) 1801-1807
31. Richelson E. Receptor pharmacology of neuroleptics: relation to clinical effects. J Clin Psychiatry 60 (1999) 5-14
32. Sorensen L., Foldspang A., Gulmann N.C., and Munk-Jorgensen P. Determinants for the use of psychotropics among nursing home residents. Int J Geriatr Psychiatry 16 (2001) 147-154
33. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85 (1985) 367-370
34. Wei Z., Bai O., Richardson J.S., Mousseau D.D., and Li X.M. Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide. J Neurosci Res 73 (2003) 364-368
35. Wei Z., Mousseau D.D., Richardson J.S., Dyck L.E., and Li X.M. Atypical antipsychotics attenuate neurotoxicity of beta-amyloid (25-35) by modulating Bax and Bcl-XL/S expression and localization. J Neurosci Res 74 (2003) 942-947
36. Williams L.S., Ghose S.S., and Swindle R.W. Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am J Psychiatry 161 (2004) 1090-1095
37. Winter B., Juckel G., Viktorov I., Katchanov J., Gietz A., Sohr R., et al. Anxious and hyperactive phenotype following brief ischemic episodes in mice. Biol Psychiatry 57 (2005) 1166-1175
38. Xu H., Chen Z., He J., Haimanot S., Li X., Dyck L., et al. Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus 16 (2006) 551-559
39. Xu H., Qing H., Lu W., Keegan D., Richardson J., Chlan-Fourney J., et al. Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci Lett 321 (2002) 65-68
40. Yan B, Bi X, He J, Zhang Y, Thakur S, Xu H, Gendron A, Kong J, Li X-M. Quetiapine attenuates spatial memory impairment and hippocampal neurodegeneration induced by bilateral common carotid artery occlusion in mice. Life Sci 2007; in press.
41. Yan B., Wang D., Xing D., Ding Y., Wang R., Lei F., et al. The antidepressant effect of ethanol extract of radix puerariae in mice exposed to cerebral ischemia reperfusion. Pharmacol Biochem Behav 78 (2004) 319-325
42. Yanagisawa D., Qi M., Kim D.H., Kitamura Y., Inden M., Tsuchiya D., et al. Improvement of focal ischemia-induced rat dopaminergic dysfunction by striatal transplantation of mouse embryonic stem cells. Neurosci Lett 407 (2006) 74-79
43. Zimnitzky B.M., DeMaso D.R., and Steingard R.J. Use of risperidone in psychotic disorder following ischemic brain damage. J Child Adolesc Psychopharmacol 6 (1996) 75-78